Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. The company is headquartered in Melbourne, Victoria and currently employs 58 full-time employees. The firm is engaged in providing genomics-based tests on health, wellness and serious disease through its EasyDNA brand. The firm offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The firm has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The firm's segments include EasyDNA and AffinityDNA. EasyDNA segment relates to EasyDNA branded test sales and expenses. AffinityDNA segment relates to AffinityDNA branded test sales and expenses.
Follow-Up Questions
GNTLF の株価パフォーマンスは？
GNTLF の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
Genetic Technologies Ltd の主な事業テーマや業界は？
Genetic Technologies Ltd は Life Sciences Tools & Services 業界、セクターは Health Care に属しています。
